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Abstract
Cervical cancer is the most common human papilloma virus (HPV) -associated cancer
and is the second leading cause of death in the world. Vaccination against HPV is
essential to reduce the incidence of HPV and subsequent morbidity and mortality.
According to the Centers for Disease Control and Prevention (CDC), approximately 79
million Americans are currently infected with HPV. The site for this DNP project was a
163-bed facility with inpatient and outpatient services in the southern United States. The
vaccination rate at the site was 48%. The facility lacked educational interventions to
prepare and remind providers to offer HPV vaccine. The purpose of this DNP project was
to address a significant gap by increasing clinician knowledge through the development
of educational materials, the design and implementation of training sessions for staff, and
the development of protocols that require providers to offer the vaccine to every eligible
patient and to call the patient and remind them of appointments for vaccine injections.
The academic center for evidence-based practice star model was used to translate
knowledge into nursing practice to improve outcomes change. For this project, a panel of
10 experts from the facility was formed to conduct a formative and summative evaluation
of the educational materials and protocols. The findings of the study showed an
acceptance of the plan suggesting the importance of the educational materials and the
educational process to increase HPV vaccination rates, which can thereby reduce death
and disease associated with HPV through the empowerment of the clinicians to provide
necessary and appropriate care.
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Section 1: Nature of the Project
Introduction
The human papillomavirus (HPV) is the most common sexually transmitted
infection. There are more than 40 types of HPV that can infect the genital area, mouth,
and throat. More than 50% of sexually active individuals will be diagnosed with genital
HPV at some point in their lives (Dunne et al., 2014). Studies show that 66% of cervical
cancers, 55% of vaginal cancers, 79% of anal cancers, and 62% of oropharyngeal cancers
are attributable to HPV Types 16 or 18 (Dunne et al., 2014). Cervical cancer is the second
leading cause of cancer deaths among women around the world (Petrosky et al., 2015).
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease
Control (CDC) recommend that routine HPV vaccination be initiated at ages 11 or 12
years. However, the vaccination series can be started as early as age 9 years. Females
aged 13 through 26 years and males aged 13 through 21 years who have not already
received the vaccine or completed the three-dose series should also be vaccinated. Males
aged 22 through 26 years, particularly those who are high risk, can also receive the
vaccine (Petrosky et al., 2015). Although vaccines are available, the HPV vaccination
rate remains low. The vaccination rate at the project facility was 48%, which is below the
Healthy People 2020 goal of 80% (Hariri et al., 2014). Developing interventions to
improve HPV vaccination at this facility can decrease the risk for HPV, associated
cancers, and death.
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The U.S. Food and Drug Administration (FDA) approved Gardasil in 2006 to
prevent HPV Types 6, 11, 16, and 18. These HPV types can cause cervical cancer, anal
cancer, and genital warts. At that time, the Gardasil vaccine was recommended for use in
females ages 9 to 26 years and was not recommended for males (FDA, 2015b). In 2009,
the FDA approved Gardasil for use in males ages 9 to 26 years to prevent genital warts
caused by HPV Types 6 and 11 (FDA, 2015b). The FDA approved Cervarix in 2009 for
females 10 to 25 years of age for the prevention of HPV types 16 and 18 (FDA, 2015a).
In 2014, Gardasil 9 was approved for females ages 9 to 26 years and males ages 9 to 15
years for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV
Types 16, 18, 31, 33, 45, 52, and 58. The five additional HPV types covered by Gardasil
9 are not covered by the previously approved vaccines (FDA, 2014). HPV vaccination
consists of three injections administered in the course of 6 months (CDC, 2015).
The project location was the women’s clinic at a 163-bed medical center in the
southern United States. The medical center provides primary, secondary, and tertiary
medical, neurological, and mental health inpatient care as well as a variety of specialized
outpatient services. Female veterans have access to comprehensive health care through
the clinic and that includes cervical and breast cancer screenings and HPV vaccine (U.S.
Department of Veterans Affairs, 2015). The target population for this project was
clinicians caring for female veterans ages 18 to 26 years at the facility. HPV is most
common in individuals in their late teens and early 20s. Most men who contract
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HPV never have symptoms and most cases usually resolve without intervention (CDC,
2015). Costs, a perception that the vaccine is not beneficial, fear, side effects, and
recommendation of a health care provider can affect vaccine acceptance (Rambout et al.,
2014).
Problem Statement
Although HPV vaccines are available, vaccination rates remain low. According to
the CDC (2013), individuals are not receiving HPV vaccine when they receive other
recommended vaccines. In 2009, a national immunization survey administered by the
CDC revealed that HPV vaccination coverage among females ages 18 to 26 years was
17.1% (CDC, 2011). In 2013, girls ages 13 to 17 years who received at least one dose of
HPV vaccine was 57.3%, whereas 91.3% of girls age 13 years would have received at
least one dose of HPV vaccine had they received it at the same time they received other
recommended vaccines (CDC, 2013). The target population for this project was clinicians
caring for female veterans ages 18 to 26 years at the VA facility. The vaccination rate at
the Jackson VAMC was 48%. Eligible patients at the facility were not accepting the
vaccine. Healthy People 2020 goals include 80% coverage of three doses of HPV
vaccines for females by ages 13 to 15 years and to reduce the death rate from cancer of
uterine cervix below a target of 2.2 deaths per 100,000 females from a baseline of 2.4
deaths per 100,000 females in 2007. There is also a goal to increase the number of
women who receive cervical cancer screening with a target of 0% of women ages 21 to
65 years from a baseline of 84.5% in 2008 (Hariri et al., 2014). Vaccination before
exposure to HPV will optimize the vaccine’s effectiveness (CDC, 2014).
The problem that I addressed in this project was the lack of education related to
HPV and its vaccines at the site. The significance of this DNP project was the
development of evidence-based protocols and interventions to increase clinician
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education and thereby increase vaccine acceptance among patients.
Purpose Statement
The purpose of this evidence-based project (EBP) was to develop interventions
that would increase HPV awareness among patients and clinicians and thereby reduce the
morbidity and mortality associated with HPV.
Project Objectives
The objectives for this project are as follows:
Objective 1: Develop evidence- based educational materials for patients and
clinicians concerning HPV and vaccination.
Objective 2: Design and implement training sessions to prepare providers and
nurses to offer HPV vaccine.
Objective 3: Develop a protocol that requires providers to offer HPV vaccine
during every encounter to eligible patients who have not received the vaccine.
Objective 4: Develop a protocol that requires staff to call patients to remind
them of appointments for follow-up vaccine injections.
Nature of Doctoral Project
The nature of the project was to address the low HPV vaccine acceptance rate.
I developed evidence-based educational materials, training sessions, and protocols that
would increase awareness and knowledge of HPV and vaccines. An expert panel
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completed a formative evaluation on the educational interventions and provided feedback.
The feedback improved the content validity and efficacy of the educational materials,
training sessions, and protocols. I gave these materials to the facility for future use.

Evidence-Based Significance of the Project
HPV vaccination has proven effective in preventing HPV infections in women as
well as cancers associated with it. Knowledge can affect HPV vaccine acceptance.
Provider recommendation has been found to be one of the strongest predictors of
vaccination (Conroy et al., 2009). According to Cates et al. (2009), low intention to
accept HPV vaccine among African Americans was associated with lower levels of
knowledge about HPV and cervical cancer. Women were also found to have limited
knowledge about HPV and vaccination (Kwan et al., 2009). Developing evidence-based
interventions to educate health care professionals and establish protocols can increase
knowledge of HPV and available vaccines among providers and thereby increase
vaccination and reduce the death and disease associated with it (CDC, 2014). Preventing
HPV and cancers will also reduce costs associated with follow-up procedures and
treatments (ACOG, 2015).
Implications for Social Change in Practice
Walden University defines positive social change as “a deliberate process of
creating and applying ideas, strategies, and actions to promote the worth, dignity, and
development of individuals, communities, organizations, institutions, cultures, and
societies” (Walden University, 2014, p.1). The interventions in this project were
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designed to raise awareness and provide education for health care providers concerning
HPV and available vaccines. This increased knowledge can be used to educate patients
and increase their likelihood of accepting HPV vaccine, thereby reducing the burden
associated with HPV. Male and female patients at risk for HPV will benefit from this
research through the evidence-based guidelines designed to improve acceptance of
HPV vaccine. Vaccinated male and female patients will have a reduced likelihood of
contracting HPV thereby increasing their opportunities for longer, healthier lives.
They will also avoid costs associated with treatment of HPV-associated conditions.
These healthy individuals can contribute to society through the development of self and
working in their organizations and communities. I also designed this project to
increase the ability of the organization to sustain changes in practice and continue to
identify and address practice problems.
Definitions of Terms
An attitude is a way of thinking or perception that makes one behave in a certain
way (Merriam-Webster, 2018a).
A barrier is an object, real or perceived, which can prevent one from performing
a behavior (Rosentsock, 1974).
Education is the action or process of gaining knowledge and skill from study or
training (Merriam-Webster, 2018b).
Human Papillomavirus is a group of more than 150 viruses that can cause warts
or cancer. There are more than 40 types of HPV. It is the most commonly sexually
transmitted infection and is spread through intimate skin-to-skin contact (CDC, 2015).
HPV vaccination is a vaccination given to protect against HPV and the potential
health problems associated with HPV infection (CDC, 2015).
Perception is the way in which one understands someone or something
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(Merriam-Webster, 2018c).
Seriousness is the possibility of being dangerous (Merriam-Webster,
2018d).
Susceptibility is the state of being affected or hurt by something
(Merriam-Webster, 2018e).
Assumptions and Limitations
The major assumption that I made in this study was that stakeholders would want
to implement the project plan and sustain it after the project was complete. I also
assumed that the rate of HPV vaccine acceptance would increase among young adult
women ages 18 to 26 years who are eligible to receive the vaccine. An additional
assumption was that after educating nurses and providers, they would offer the vaccine
to each eligible patient, identify potential and actual barriers, and develop a plan to
reduce or eliminate those barriers.
One can furthermore assume that education and knowledge can lead to behavior
change. A limitation of this study was that the results may not be generalizable to other
locations or populations. Only health care providers at the women’s clinic at the project
facility received education, training, and protocols. The study did not include adult
males or adolescent males or females.
Summary
HPV affects millions worldwide, increasing their risk for cervical cancer. HPV
vaccine acceptance rates remain low, despite available vaccines. It is essential to
vaccinate individuals before exposure so that immunity to HPV can be developed. The
purpose of this EBP was to effectively design interventions and protocols aimed at
increasing the knowledge of HPV and available vaccines among health care providers.
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Section 2: Background and Context
Introduction
HPV is the most common sexually transmitted infection and is associated with
several types of cancer. Although vaccines to protect against HPV are available, vaccine
acceptance remains low. The purpose of this EBP was to raise awareness of HPV and
vaccines among patients and clinicians and to develop measures that will increase HPV
vaccine acceptance among females ages 18 to 26 years. I will also explain the theoretical
framework that I used to guide this project. The HPV vaccination rate at the project site
was 48% which is significantly below the Healthy People 2020 goal of 80% (Hariri et al.,
2014). Low vaccination rates have been associated with various barriers, which include a
lack of provider and patient knowledge, side effects, costs, lack of time, and a belief that
the vaccine is not needed by individuals who are not sexually active (Al-Dubai et al.,
2010; Downs et al., 2010; Paul, LaMontagne, & Le, 2012; Rose, Lanumata, & Lawton,
2011). Research shows that motivators to receiving HPV vaccine include education from
a credible source and advice from individuals who had received the vaccine (Downs et
al., 2010). Developing interventions to improve HPV vaccination at this facility can
decrease the risk for HPV, associated cancers, and death.
The evidence-based interventions that I designed for this project were based on the
health belief model (HBM). Interventions designed to increase knowledge concerning
HPV and available vaccines among health care providers can better equip them to assess
and address a patient’s perceived seriousness of HPV, perceived susceptibility to HPV,
perceived benefits of HPV vaccination, and perceived barriers to HPV vaccination, which
can increase the acceptance of HPV vaccine among veterans and thereby decrease the
morbidity and mortality associated with it.
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Conceptual Model and Theoretical Framework
I used the academic center for evidence-based practice (ACE) star model as a
framework for developing the interventions and protocols that will translate knowledge
into nursing practice to improve outcomes (Appendix D). The model consists of five
steps: finding new knowledge, summary of evidence, incorporating evidence into
practice, implementation of practice change, and evaluation of the effects of practice
change (Schaffer, Sandau, & Diedrick, 2013). The HBM is based on the concept that
health behavior is determined by personal beliefs, perceptions about a disease, and
measures to decrease its occurrence (Appendix E). Originally developed in the 1950s by
social psychologists Hochbaum, Rosenstock, and Kegels to determine the reason for
unsuccessful medical screening programs offered by the U.S. Public Health Service, the
HBM is the most commonly used theory in health education and health promotion
(Rosenstock, 1966). The model is composed of four main perceptions: perceived
seriousness, perceived susceptibility, perceived benefits, and perceived barriers
(Rosenstock, 1966). Each perception can be used either individually or in combination to
explain health behavior such as the acceptance of the HPV vaccination (Sharma &
Romas, 2012). I could not find studies that cited the title by Rosenstock, Hochbaum, or
Kegels until Rosenstock’s 1966 work (Rosenstock, 1966). A perceived barrier is the
most significant construct determining human behavior change (Janz & Becker, 1984).
In the HBM, perceived barriers and benefits of a behavior influence one’s likelihood of
taking recommended action (Sharma & Romas, 2012).
Relevance to Nursing Practice
Health care providers, media, and other sources can influence an individual’s
hesitancy towards vaccination. Hesitancy is a concern or doubt about the benefit or safety
of vaccine. Lack of knowledge and trust can play a role in vaccination attitudes (Yaqub
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et al., 2014). Head, Vanderpool, and Mills (2013) conducted a study to explore the
perspectives of health care providers in Appalachian Kentucky on barriers and facilitators
to HPV vaccination and their recommendations for improving vaccination rates. Previous
research in Appalachian Kentucky had revealed a low uptake and adherence to HPV
vaccination among females ages 18 to 26 years, even though the vaccine was offered at
no cost. The results revealed that poor communication and a lack of HPV vaccine
education were the primary reasons for low acceptance. The researchers concluded that
more targeted education efforts and patient-centered reminder systems could prove
beneficial in increasing vaccine acceptance and adherence.
Wong et al. (2013) conducted a study among primary care physicians in Hong
Kong to assess knowledge toward, attitude toward, practices of, and barriers to
recommending HPV vaccines. They found that knowledge of HPV infection was low
among physicians and concluded that educational initiatives should target physicians
(Wong et al., 2013). Research has also shown that individuals are more likely to accept
HPV vaccine if a clinician recommended the vaccine to them (Kang & Moneyham,
2010). Studies have also shown that vaccine recall and reminder systems have proven
effective in increasing vaccine acceptance rates (Conroy et al., 2009).
The evidence-based interventions that I designed for this project were based on
the HBM, which is composed of four main concepts: perceived seriousness, perceived
susceptibility, perceived benefits, and perceived barriers; these concepts can explain
health behaviors, such as the acceptance of the HPV vaccination (Gerend & Shepherd,
2012). Interventions that were designed to increase knowledge concerning HPV and
available vaccines among VA health care providers can better equip them to assess and
address a patient’s perceived seriousness of HPV, perceived susceptibility to HPV,
perceived benefits of HPV vaccination, and perceived barriers to HPV vaccination,
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which can increase the acceptance of HPV vaccine among veterans and thereby decrease
the morbidity and mortality associated with it.
Local Background and Context
A lack of awareness of HPV and available vaccines among clinicians at the
project facility was a barrier to HPV vaccine acceptance among patients. It was therefore
essential to develop educational materials and protocols. The target population for this
project was clinicians caring for female veterans ages 18 to 26 years at the VA project
facility. The HPV vaccination rate was 48%. It is essential that clinicians have evidencebased guidelines for their practice so that they can educate patients. The evidence-based
education materials in this project reflected CDC standards.
Role of the DNP Student
As a DNP student, my role in this project was to provide the facility with
evidence-based educational materials, training session plan, protocols, and a long-term
evaluation method for future use when the items were implemented. I designed the
educational materials to increase the staff’s knowledge of HPV and available vaccines.
Furthermore, I developed the materials to teach staff how to identify and minimize or
eliminate potential barriers to vaccination. The protocols that I developed require staff to
call and remind patients of follow-up appointments. Other protocols require providers to
offer the vaccine to every eligible patient. As a student, I developed educational
materials, training plans, and protocols. I also developed a panel of experts for a
formative evaluation of the educational materials, training session plans, and protocols
to increase validity.
Summary
Research has shown that HPV can cause several types of cancers, including
cervical cancer. HPV vaccines can protect against certain types of HPV and thereby
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reduce one’s risk for the cancers associated with this disease. The HBM was the
framework that I used to guide this project and develop interventions and a protocol that
would raise awareness of HPV and vaccines to increase vaccine acceptance, and thereby
decrease the morbidity and mortality associated with HPV.
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Section 3: Collection and Analysis of Evidence
Introduction
I conducted an exhaustive review of the literature through the Walden University
online library using Thoreau Multi-Database, CINAHL Plus with Full Text, and
MEDLINE with Full Text. The following key terms in the search were HPV,
vaccination, acceptance, cervical cancer, facilitators, attitudes, and barriers. Exclusion
criteria included articles greater than 10 years old and those written in a language other
than English. Inclusion criteria included the terms HPV, vaccine, and education. The
review included studies concerning barriers to and attitudes towards HPV vaccination.
This section outlines specific and general literature related to HPV and vaccines designed
to protect it as well as measures that have proven effective in increasing vaccine
acceptance.
Practice-Focused Question
The PICO format—patient population, intervention, comparison intervention or
group, and outcome—served as a guideline for the development of an appropriate,
relevant project question (Malhotra, 2013). The question for this project was as follows:
Will evidence-based education and protocols increase HPV vaccine acceptance among
young women ages 18 to 26 years?
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Sources of Evidence
Specific Literature
Researchers have suggested that the HPV vaccine remains effective for at least
10 years, and there has been no evidence to suggest that HPV vaccine loses its ability
to protect against HPV with time. HPV vaccine is continuously monitored for safety
and effectiveness. According to the CDC (2014), clinical trials have shown the
vaccines provide 100% protection against precancers and genital warts. Since the
approval and recommendation of vaccines in 2006, HPV infections have declined by
56% in teenage girls in the United States. The incidence of genital warts has also
decreased. In countries, such as Australia, that have greater HPV vaccination coverage,
there has been a reduced incidence of precancers of the cervix among women in the
country (CDC, 2014).
Education, which can eliminate barriers while promoting vaccination, is an
important part of health care. It is therefore essential that providers are educated and
trained so that they can offer vaccines to eligible patients. Barriers to vaccination include
cost, a perception that the vaccine is not necessary, and concerns about vaccine safety
and side effects. Facilitators to vaccination include perceived benefit of vaccination,
recommendation of a health care provider, and social norms (Rambout et al., 2014).
Gorin and Westhoff (2009) identified specific level barriers. Provider level barriers are
physician knowledge about HPV and physician recommendation that can have a strong
influence on HPV vaccine acceptance. Some providers find it challenging to discuss
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sexually transmitted infections, and others are reluctant to store a vaccine that is less
often requested. Policy level barriers are access to health care, insurance coverage,
vaccine availability, limited knowledge of HPV vaccine, and media coverage with
stigmatizing effects. At the patient level, barriers include limited awareness of the
vaccine; socioeconomic status; perception of risk based on sexual history; fear of vaccine
safety; and socio-cultural, economic, and religious factors. Both providers and patients
can benefit from further education on ways to effectively discuss sexually transmitted
infections such as HPV and offer vaccinations (Gorin & Westhoff, 2009).
Attitudes, beliefs, and behaviors related to HPV can also affect the acceptance
of HPV vaccine. Bendik, Mayo, and Parker (2011) found a positive correlation between
having received HPV vaccine and knowledge score. The researchers found that among
those who had not received the vaccine, 35.4% revealed that “my doctor tells me to get
it” would be a motivating factor, followed by “I find a way to pay for the vaccine”
(19.5%), “my parents tell me to get it” (16.4%), “I become sexually active” (14%), and
“I start having sex with more partners” (9.6%). Recommendations from parents and
doctors in addition to perceiving HPV as severe were prevalent and strongly associated
with previous vaccination. Results suggest that increased education about the vaccine
and the importance of physician recommendation will prove beneficial in increasing
vaccine acceptance (Bendik et al., 2011). Conroy et al. (2009) conducted a similar study
to assess HPV vaccine uptake, predictors of vaccination, and barriers to vaccination
among females ages 13 to 26 years at an urban clinic. The researchers concluded that

16
interventions to increase HPV vaccination rates should target costs, promote HPV
vaccination as routine, and establish clinic-based systems to ensure that the vaccine is
offered to eligible individuals (Conroy et al., 2009). Reminder/recall (R/R) messages
have proven beneficial in increasing vaccination rates. Half of the parents of young
children ages 19 to 35 months who participated in a study favored an R/R message with
mail being the preferred method (Saville et al., 2014). Assigning a dedicated staff
member to deliver R/R messages improves the likelihood of success (Saville et al., 2011)
General Literature
Electronic-derived immunization prompts have proven to increase vaccine uptake.
Clinical decision support tools can serve as reminders for overdue immunizations. In a
study conducted by Bundy et al. (2013), these prompts resulted in the highest rates for
completion of HPV vaccination series in four of five quarters (Bundy et al., 2013).
Protocols should be in place to guide providers to offer the vaccine to eligible patients. A
study among young men ages 18 to 22 years from African American, Haitian, Caucasian,
and Latino racial groups revealed perceived benefits as protection from anal and oral
cancer, good health, and the prevention of disease transmission. These men were more
likely to accept HPV vaccine when their concerns were addressed honestly during a
doctor’s appointment. Perceived barriers to vaccination included lack of knowledge, side
effects, fear of needles, and cost. Side effects such as bleeding and insanity were some of
the concerns voiced by participants which highlighted the lack of knowledge among men
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in these racial groups.
Culturally competent education could prove beneficial in reducing the ethnic
differences in attitudes, beliefs, and behaviors concerning vaccination among young men
(Pierre et al., 2014). Other studies have confirmed that barriers to vaccination include a
lack of awareness, fear of needles, fear of social stigma, lack of time, costs,
inconvenience, and a belief that the vaccine is not needed if one is not sexually active
(Al-Dubai et al., 2010; Downs et al., 2010; Paul et al., 2012; Rose et al., 2011). Downs et
al. (2010) discovered that motivators for HPV vaccine acceptance among African
American women were education, affordable prices, good results with the vaccine, and
knowledge of individuals who had received HPV vaccine. Motivators among Latinas
included having more than one credible source of information such as educational talks,
doctor’s office, television, churches, and advice from women who had received the
vaccine. Knowledge of perceived barriers to HPV vaccination is essential to the
development of educational initiatives that will decrease existing disparities in cervical
cancer incidence and mortality.
Bastani et al. (2011) explored the low HPV vaccine acceptance rates in lowincome, ethnic minority, and immigrant populations in the United States. Between
January 2009 and November 2009, 490 telephone interviews were conducted in six
languages among mothers of vaccine-eligible girls ages 9 to 18 years using the Los
Angeles County Department of Public Health, Office of Women’s Health service referral
hotline. HPV and vaccine awareness, knowledge, beliefs, barriers, and daughters’ vaccine
receipts were assessed. Only 29% of daughters initiated the vaccine
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and 11% received all three doses. No ethnic differences were observed in initiation or
completion rates. Ethnic differences were observed in HPV awareness, perceived risk,
and other vaccine-related beliefs. Vaccine awareness was the strongest predictor of
initiation (Bastani et al., 2011). For the barrier “need more information to make a
decision,” 64% of the Latina population rated this as a barrier, whereas 81% of the
Chinese, 66% of the Korean, and 41% of the African American populations also rated
this as a barrier. A total of the 74% of the population rated “do not know where to go to
get the vaccine” as a barrier, with 68% of the Latina, 84% of the Chinese, 81% of the
Korean, and 68% of the African American populations agreeing with this statement. The
barrier “thinks HPV vaccine may cause problems getting pregnant in the future” was
noted by 17% of the total population, including 16% of the Latina, 19% of the Chinese,
4% of the Korean, and 56% of the African American population. “Thinks HPV vaccine
may cause health problems in the future” was rated as a barrier by 15% of the total
participants. It was rated as a barrier by 11% of Latinas, 24% of Chinese, 4% of Koreans,
and 44% of African Americans. Of the total mothers, 13% believed their daughters may
think it is okay to have sex after getting the HPV vaccine; 11% of Latina mothers noted
this barrier as significant, as did 15% of Chinese mothers, 0% of Korean mothers, and
11% of African American mothers (Bastani et al., 2011). This study suggests that
adequately trained health care professionals and established protocols that guide
professionals to offer the vaccine can reduce barriers associated with HPV vaccine
acceptance.
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Analysis and Synthesis
The purpose of this proposed project was to develop an educational intervention
and protocol that would raise awareness of HPV and available vaccines among providers
and establish protocols that will increase HPV vaccine acceptance among females ages
18 to 26 years. I conducted a literature review. The evidence supported the development
of a quality improvement project consisting of educational materials, a training session,
protocols, and a long-term evaluation plan that will help providers and nurses offer HPV
vaccine to every patient. I also formed a panel of experts to conduct a formative and
summative evaluation of the educational materials and protocols. After obtaining
institutional review board (IRB) approval, I presented the quality improvement project
components to the expert panel in a classroom setting using a face-to-face approach and
PowerPoint presentation (Appendix A). The director of the women’s clinic provided
contact information for health care professionals working in the women’s clinic. Each
professional was notified via e-mail and informed of the problem identified in the
women’s clinic. The 10 participants who volunteered to participate in the project were
notified of the date, time, and location for the formative evaluation of the educational
materials, training session, and protocols. I emailed the presentation agenda 1 week prior
to the presentation.
Population and Sampling
The population for this study was a 10-member expert panel consisting of
clinicians in the women’s clinic at the facility. The sample included one doctor who
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was medical director of the women’s clinic, two advanced practice nurses, six registered
nurses, and one nurse educator. This sample was effective because I focused on
education for health care providers. The panel conducted a formative evaluation.
Analysis of the answers provided by the respondents led to development of descriptive
statistics that answers research questions. The formative and summative groups
conducted a two-step process to evaluate the quality of the guideline prior to
finalization of the guideline.
Protection of Human Subjects
For the protection of human subjects, I submitted the necessary paperwork to
obtain approval from VA facility prior to developing educational interventions and
protocols to improve HPV vaccination rates. Walden University IRB also granted
approval.
Project Evaluation Plan
The expert panel reviewed the materials for the Formative and Summative
assessment. Data collection was done using a tool based on the ADDIE. The
University of Texas Medical Branch at Galveston granted permission to use an adapted
version of this tool (Appendix B). The validated ADDIE tool is both a quantitative and
qualitative formative evaluation tool that provides data on the efficacy and content
validity of projects. The survey contains 14 closed-ended questions
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followed by an open-ended comment section. The practice site received the results first.
An expert panel conducted a formative evaluation of the educational materials and
protocols that I developed and provided recommendations (Appendix C). I revised the
materials and protocols based on the feedback. The expert panel conducted a final
summative evaluation. The facility may choose to conduct a long-term evaluation, which
will include facility data extracted from the electronic health record concerning HPV
vaccination acceptance by women ages 18 to 26 years.
Summary
Reducing the burden associated with HPV will require unique interventions aimed
at educating health care providers and establishing protocols to ensure that eligible
patients are offered the vaccine and reminded of appointments. In this section, I addressed
how this project will be developed and implemented in addition to measures that will be
taken to evaluate effectiveness.
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Section 4: Findings and Recommendations
Introduction
Data analysis leads to clear findings that answer research questions. The data
collection tools influenced the nature of data that I used in this research. The findings are
essential in reduction of the burden associated with HPV. In this section, I address the
findings and implications from the collected data.
Findings and Implications
In the summative evaluation, all members of the committee approved the plan.
The 10 respondents also conducted the formative evaluation. The target population for
this project was clinicians caring for female veterans ages 18 to 26 years in a women’s
clinic at a VA facility. The formative evaluation form is an indicator of the level of
agreement. Each of the questions in the formative evaluation form had the same response
for all the 10 respondents. The responses in this case were all in agreement. Formative
evaluation involved evaluation of educational materials and protocols to improve HPV
vaccination rates. Table 1 shows the responses in the formative evaluation.
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Table 1
Formative Group Questionnaire
Question

Response

Number of participants

Yes

10

Yes

10

Yes

10

Q4: Is the educational material appropriate for
the learner’s personal background (e.g., age,
nationality, previous experiences, interests,
cultural background)?

Yes

10

Q5: Does the educational material identify what
the learner needs to accomplish at the end of the
program?

Yes

10

Q6: Can you identify the desired outcomes to be
achieved through this protocol?

Yes

10

Q7: Does this educational material address
aspects of current practices that need to be
improved upon?

Yes

10

Q8: Can you identify the instructional goals and
target objectives for this program?

Yes

10

Q9: Will the described environment in which
the program is to be conducted be a conductive
learning environment?

Yes

10

Q10: Are there limiting factors that must be
considered with regards to resources, technical
support, time, technical skills, financial factors,
and supporting factors that are needed to make
this program successful?

Yes

10

Q11: Is the proposed educational media
appropriate for the target audience?
Q12: Is the proposed time frame for the
educational program appropriate?

Yes

10

Yes

10

Q13: Is the method to determine acquisition of
acquired competencies appropriate?

Yes

10

Q14: Is the mechanism that will be used to
obtain learners’ feedback on material learned
appropriate?

Yes

10

Q1: Is the target audience clearly identified?
Q2: Is the educational level and job
description of the participants aligned with
the educational materials?
Q3: Is the job description of the participants
aligned with the educational materials?
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Each of the 10 members responded to all 14 questions. The questions asked were
aligned with the objectives of the study. The answers of all respondents for all questions
are similar. There was a 100% positive response for each question in evaluation of
educational materials and protocols to improve HPV vaccination rates. The responses
can generate descriptive statistics for each question to yield a conclusion. Evaluation of
the information given by the formative group reveals a clear conclusion that there is
agreement that the educational materials and protocols would greatly improve HPV
vaccination rates. The percentage of agreement is at 100% meaning that the sample
population is of the point of view that the educational materials would have a significant
effect on HPV vaccination rate. The formative group provided recommendations for the
development of educational materials in the comment boxes of the evaluation
(Appendix B). The summative group responses outlined in Table 2 also show 100%
agreement.

Table 2
Summative Group Questionnaire
Question

Response

Number of participants

Yes

10

Yes

10

Yes

10

Q4: Is the educational material appropriate for
the learner’s personal background (e.g., age,
nationality, previous experiences, interests,
cultural background)?

Yes

10

Q5: Does the educational material identify what
the learner needs to accomplish at the end of the
program?

Yes

10

Q1: Is the target audience clearly identified?
Q2: Is the educational level and job
description of the participants aligned with
the educational materials?
Q3: Is the job description of the participants
aligned with the educational materials?
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Q6: Can you identify the desired outcomes to be
achieved through this protocol?

Yes

10

Q7: Does this educational material address
aspects of current practices that need to be
improved upon?

Yes

10

Q8: Can you identify the instructional goals and
target objectives for this program?

Yes

10

Q9: Will the described environment in which
the program is to be conducted be a conductive
learning environment?

Yes

10

Q10: Are there limiting factors that must be
considered with regards to resources, technical
support, time, technical skills, financial factors,
and supporting factors that are needed to make
this program successful?

Yes

10

Q11: Is the proposed educational media
appropriate for the target audience?
Q12: Is the proposed time frame for the
educational program appropriate?

Yes

10

Yes

10

Q13: Is the method to determine acquisition of
acquired competencies appropriate?

Yes

10

Q14: Is the mechanism that will be used to
obtain learners’ feedback on material learned
appropriate?

Yes

10

The findings of the study additionally show that HPV is the most common
sexually transmitted infection and has been associated with several cancers. The research
shows hesitancy toward vaccination and a low vaccination rate. Cervical cancer is the
second leading cause of death in the world. Research suggests that there is need to
improve HPV vaccination rates. Gardasil and Cervarix are among the available vaccines
for the HPV virus. The potential barriers to HPV vaccination include the cost, limited
awareness, and concerns about safety and side effects. The research shows that ways to
minimize these barriers include routinely promoting HPV vaccination, exploring cost
with insurance, and educating providers and patients about HPV. Summative and
formative assessment suggests strong agreement that education material would improve
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HPV vaccination rates by raising awareness. The summative evaluation had individuals
who all agreed. All the individuals are care givers.
Recommendations
Educational protocols and interventions can prove beneficial in increasing vaccine
acceptance. There is need to increase awareness on HPV vaccination. Reducing the
burden associated with HPV requires unique interventions aimed at educating health care
providers and establishing protocols to ensure that eligible patients are offered the
vaccine and reminded of appointments. I recommend that clinicians in the project facility
implement the educational materials and protocols into their practice and develop a longterm evaluation plan to measure effectiveness.
Project Strengths and Limitations
My study has strengths and limitations. The methodology of the study is among
the strengths. A limitation, however, is in the sample population being limited to
clinicians in the women’s clinic who care for individuals of a specific age and gender.
The target population for this project is clinicians caring for female veterans ages 18 to
26 years at the VA facility. A limitation of this study is that the results may not be
generalizable to other locations or populations. Only health care providers at the
women’s clinic at the VA facility received education, training, and protocols. I did not
include adult males or adolescent males or females in my study. The selected participants
in the formative group are professionals. All the participants in the formative and
summative groups returned their evaluations. Generalizability of a research is important
in making it useful in different areas. There are aspects of the study that may be
limitations or strengths depending on the point of view.
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Section 5: Dissemination Plan
Analysis of Self
In my opinion, I did a thorough job with the project. My work remained
objective and without bias. During the project, I received constructive criticism and used
it to make improvements under the guidance of my committee. The 100% agreement by
the summative group is an indicator of the effectiveness of the education material. I was
satisfied with the presentation and gained new knowledge and skills from this research
process. I will apply the knowledge and skills learned to improve in my role as a
clinician. This project helped me to identify real and potential problems in practice,
conduct a literature review, implement interventions based on evidence, and evaluate the
effectiveness of those interventions before finally reaching a conclusion.
Dissemination Plan
The results of this DNP project will be presented during the National Research
Week, a symposium where various clinicians present research projects completed at the
facility. I will use a poster presentation to present the findings. A PowerPoint
presentation of the results will be delivered during a monthly meeting of the project
facility’s Evidence-Based Research Committee. The results will also be published in the
Federal Practitioner, which is a peer-reviewed journal for health care professionals of
the VA. I also plan to present the results in a poster presentation at the Mississippi Nurses
Association state conference and the American Association of Nurse Practitioners
national conference.
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Summary and Conclusions
HPV is the most common sexually transmitted infection and has been associated
with various types of cancer. Although vaccines to protect against HPV are available,
vaccination rates remain low. The purpose of this project was to develop interventions
and protocols based on evidence that will improve clinician knowledge of HPV and its
vaccines. This improvement in education and knowledge can improve vaccine acceptance
and thereby reduce the death and disease caused by the cancers associated with HPV.
Trained clinicians who have been educated can identify eligible patients and offer the
vaccine effectively. They can also identify and reduce or eliminate potential barriers to
vaccination. Their actions will likely improve HPV vaccine acceptance and in turn reduce
the incidence of HPV. In this project, I provided a short-term plan to improve knowledge
of HPV and its vaccine. I also plan to assist with the development of a long-term
evaluation plan, which will involve an extraction of data from the charts to measure any
changes in the HPV vaccination rate at the VA facility. Dissemination of the results of
this project will include professionals at the local, state, and national levels.
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Appendix B: Evaluation of Educational Materials and Protocols to Improve HPV
Vaccination Rates
1. Is the target audience clearly identified?
Yes
No
Comment:
2. Is the educational level and job description of the participants aligned with the
educational materials?
Yes
No
Comment:
3. Is the job description of the participants aligned with the educational
materials?
Yes
No
Comment:
4. Is the educational material appropriate for the learner’s personal background
(e.g., age, nationality, previous experiences, interests, cultural background)?
Yes
No
Comment:
5. Does the educational material identify what the learner needs to accomplish at
the end of the program?
Yes
No
Comment:
6. Can you identify the desired outcomes to be achieved through this protocol?
Yes
No
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Comment:

7. Does this educational material address aspects of current practices that need to be
improved upon?

Yes
No
Comment:
8. Can you identify the instructional goals and target objectives for this program?

Yes
No
Comment:
9. Will the described environment in which the program is to be conducted be a
conductive learning environment?

Yes
No
Comment:
10. Are there limiting factors that must be considered with regards to resources,
technical support, time, technical skills, financial factors, and supporting factors that
are needed to make this program successful?
Yes
No

Comment:
11. Is the proposed educational media appropriate for the target audience?

Yes
No
Comment:
12. Is the proposed time frame for the educational program appropriate?

Yes
No
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Comment:
13. Is the method to determine acquisition of acquired competencies appropriate?

Yes
No
Comment:

14. Is the mechanism that will be used to obtain learners’ feedback on material learned
appropriate?

Yes
No
Comment:

Adapted from: pedi.edtech – a faculty development program of the University of Texas
Medical Brach and Galveston, with support from the US Department of Health and
Human Services, Health Resources and Services Administration, Bureau of Health
Professions.
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Appendix C: Recommendations for Development of Education Material for Both
Providers and Patients
•

Use simple wording and cartoon
illustrations. This involves using
language that can be understood
by laymen.

•

Address common misconceptions
and myths about HPV and HPV
vaccination. Using evidence-based
approaches can eliminate myths.
Myths may negatively influence
vaccine acceptance.

•

Use of visual aids and
demonstrations as applicable.

•

Adopting modern technology as
part of the education strategy is
essential, for example the use of
social media.
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Appendix D: The ACE Star Model
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Appendix E: Health Belief Model

